Report cover image

United Kingdom Orthobiologics Market Outlook to 2033 - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators and Others

Publisher GlobalData
Published Sep 04, 2025
Length 52 Pages
SKU # GBDT20418682

Description

United Kingdom Orthobiologics Market Outlook to 2033 - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators and Others

Summary

GlobalData’s “United Kingdom Orthobiologics Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United Kingdom Orthobiologics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation

The United Kingdom Orthobiologics Market report provides key information and data on -
  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2023 company share data for Orthobiologics Market.
  • Global corporate-level profiles of key companies operating within the United Kingdom Orthobiologics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope

United Kingdom Orthobiologics is segmented as follows -
  • Cartilage Repair
  • Bone Grafts and Substitutes
  • Bone Growth Stimulators
  • Soft Tissue Biologics
  • Viscosupplementation
Reasons to Buy

The United Kingdom Orthobiologics Market report helps you to develop -
  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

52 Pages
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Orthobiologics Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Orthobiologics Market, United Kingdom
3.1 Orthobiologics Market, United Kingdom, Revenue ($m), 2018-2033
3.1.1 Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.1.2 Bone Growth Stimulators Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.1.3 Cartilage Repair Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.1.4 Soft Tissue Biologics Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.1.5 Viscosupplementation Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.2 Orthobiologics Market, United Kingdom, Volume (Units), 2018-2033
3.2.1 Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.2.2 Bone Growth Stimulators Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.2.3 Cartilage Repair Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.2.4 Soft Tissue Biologics Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.2.5 Viscosupplementation Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.3 Orthobiologics Market, United Kingdom, Average Price ($), 2018-2033
3.4 Orthobiologics Market, United Kingdom, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in United Kingdom, Orthobiologics Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Sanofi
4.2.1 Company Overview
4.3 Enovis Corp
4.3.1 Company Overview
4.4 Arthrex Inc
4.4.1 Company Overview
4.5 Stryker Corp
4.5.1 Company Overview
4.6 Orthofix Holdings Inc
4.6.1 Company Overview
4.7 Zimmer Biomet Holdings Inc
4.7.1 Company Overview
4.8 Fidia farmaceutici SpA
4.8.1 Company Overview
4.9 Bioventus Inc
4.9.1 Company Overview
5 Orthobiologics Market Pipeline Products
6 Recent Developments
6.1 Corporate Communications
6.1.1 Aug 21, 2024: AGFA HealthCare Announces the UK AGFA HealthCare User Group
6.2 Financial Announcements
6.2.1 Jan 30, 2025: Tissue Regenix Group Announces Full Year Trading Update
6.2.2 Sep 10, 2024: Tissue Regenix Group Announces Interim Results for Six Months Ended June 30, 2024
7 Appendix
7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Market Modeling and Forecasting
7.1.5 Company Share Analysis
7.1.6 Benchmarking
7.2 GlobalData Consulting
7.3 Contact Us
7.4 Disclaimer
List of Tables
Table 1: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 2: Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 3: Bone Growth Stimulators Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 4: Cartilage Repair Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 5: Soft Tissue Biologics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 6: Viscosupplementation Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 7: Orthobiologics Market, United Kingdom, Volume (Units), 2018-2033
Table 8: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), 2018-2033
Table 9: Bone Growth Stimulators Market, United Kingdom, Volume (Units), 2018-2033
Table 10: Cartilage Repair Market, United Kingdom, Volume (Units), 2018-2033
Table 11: Soft Tissue Biologics Market, United Kingdom, Volume (Units), 2018-2033
Table 12: Viscosupplementation Market, United Kingdom, Volume (Units), 2018-2033
Table 13: Orthobiologics Market, United Kingdom, Average Price ($), 2018-2033
Table 14: Orthobiologics Market, United Kingdom, Company Share by Revenue ($m), 2024
Table 15: Orthobiologics Market Pipeline Products
Table 16: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country
List of Figures
Figure 1: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 2: Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 3: Bone Growth Stimulators Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 4: Cartilage Repair Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 5: Soft Tissue Biologics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 6: Viscosupplementation Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 7: Orthobiologics Market, United Kingdom, Volume (Units), 2018-2033
Figure 8: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), 2018-2033
Figure 9: Bone Growth Stimulators Market, United Kingdom, Volume (Units), 2018-2033
Figure 10: Cartilage Repair Market, United Kingdom, Volume (Units), 2018-2033
Figure 11: Soft Tissue Biologics Market, United Kingdom, Volume (Units), 2018-2033
Figure 12: Viscosupplementation Market, United Kingdom, Volume (Units), 2018-2033
Figure 13: Orthobiologics Market, United Kingdom, Company Share (%), 2024

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us